LIGAND PHARMACEUTICALS INC shareholders Q3 2023

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

LIGAND PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
WELLS FARGO & COMPANY/MN 4,511$270,2690.00%
NISA INVESTMENT ADVISORS, LLC 716$42,9030.00%
US BANCORP \DE\ 81$4,8540.00%
Covestor Ltd 5$00.00%
Walleye Capital LLC 2,469$147,9420.00%
FRANKLIN RESOURCES INC 13,628$816,5900.00%
UBS Group AG 6,916$414,4060.00%
Amundi 2,024$111,3000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 11,522$6920.00%
CITIGROUP INC 8,777$525,9180.00%
ST GERMAIN D J CO INC 75$4,4940.00%
Daiwa Securities Group Inc. 63$40.00%
NewEdge Advisors, LLC 2$1200.00%
UBS ASSET MANAGEMENT AMERICAS INC 15,739$943,0800.00%
Steward Financial Group LLC 3$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 566$33,9140.00%
JANE STREET GROUP, LLC 16,417$983,7070.00%
CWM, LLC 391$230.00%
Parallel Advisors, LLC 1$600.00%
FARMERS & MERCHANTS INVESTMENTS INC 13$7790.00%
External links

This page lists LIGAND PHARMACEUTICALS INC's shareholders in Q3 2023. To view LIGAND PHARMACEUTICALS INC's shareholder history, click here.